Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AARD vs GWRS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GWRS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 10–0 Matrix Metrics)

GWRS Overall Winner 6-Pillar Tally: AARD 1 – 5 GWRS Matrix Metrics: AARD 0 – 10 GWRS

As of Nov 20, 2026, Global Water Resources, Inc. (GWRS) is the stronger overall head-to-head candidate over Aardvark Therapeutics, Inc. (AARD) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AARD carries a Unified Composite Score of 45.9/100 (HOLD) at $0.92 (N/M Forward P/E, 0.0% operating margin), whereas GWRS carries 52.7/100 (HOLD) at $6.40 (58.2x Forward P/E, 12.6% operating margin).

  • Technical & Structure Timing Caution: AARD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.6); meanwhile GWRS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AARD vs GWRS
AARD NASDAQ
Aardvark Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.92
-7.74% 1D
Market Cap $21.9M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.84β · 284% Vol
Unified Composite Score
45.9 / 100 HOLD
Tech 35.0 Fund 54.0 Flow 68.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -36.6%), weak momentum, RSI 29
RSI-14: 28.6 · SMA20: $1.25 · SMA50: $3.35
GWRS NASDAQ Head-to-Head Winner
Global Water Resources, Inc.
Water Supply
$6.40
+0.0% 1D
Market Cap $191.6M
TTM Revenue $61M
Forward P/E 58.2x
Beta / 30D Vol 0.30β · 40% Vol
Unified Composite Score
52.7 / 100 HOLD
Tech 55.0 Fund 53.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.1%), weak momentum, RSI 27
RSI-14: 26.7 · SMA20: $7.24 · SMA50: $7.77

6-Pillar Scorecard Institutional Category Breakdown (AARD 1 – 5 GWRS)

Columns: Metric · AARD · GWRS
1. Valuation Multiples GWRS
Forward P/E N/M 58.2x
Trailing P/E N/M 80.0x
PEG Ratio N/M 2.89x
EV / Revenue N/M 3.1x
2. Growth & Scale GWRS
Revenue Growth (YoY) +0.0% +5.0%
Earnings Growth (YoY) +0.0% -50.0%
TTM Revenue (USD) N/A $61M
Market Cap $21.9M $191.6M
3. Profitability & Quality GWRS
Gross Margin N/A 71.7%
Operating Margin 0.0% 12.6%
Net Profit Margin 0.0% 4.0%
Return on Equity (ROE) -66.0% 2.6%
4. Balance Sheet & Cash Flow GWRS
Cash Generation (TTM) N/A $26M EBITDA
Cash Flow Margin N/A 42.3% EBITDA Mgn
Net Cash / Leverage $73M Net Cash $3.13 Book/Sh · 2.6% ROE
Dividend Yield None (0.00%) 4.66%
5. Options & Positioning AARD
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 147.3% (26th %ile) 60.9% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat GWRS
OpEx & R&D Intensity N/A 59.1% of Rev ($36M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Utilities - Regulated Water Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AARD (0) vs GWRS (10)
Institutional Metric AARD GWRS Criterion Row Edge
Market Capitalization
Scale
$21.9M $191.6M Larger Scale GWRS
Trailing P/E Ratio
Valuation
N/M 80.0x Lower Multiple GWRS
Forward P/E Ratio
Valuation
N/M 58.2x Lower Multiple GWRS
Revenue Growth (YoY)
Growth
+0.0% +5.0% Higher Growth GWRS
Operating Margin (TTM)
Profitability
0.0% 12.6% Higher Margin GWRS
Net Profit Margin
Profitability
0.0% 4.0% Higher Margin GWRS
Return on Equity (ROE)
Capital Efficiency
-66.0% 2.6% Higher ROE GWRS
52-Week Range Position
Momentum
0% ($1–$17) 2% ($6–$10) Stronger Trend GWRS
Beta / 30D Volatility
Risk Regime
3.84β · 284% Vol 0.30β · 40% Vol Lower Realized Risk GWRS
Unified Institutional Score
Composite Signal
45.9 / 100 (HOLD) 52.7 / 100 (HOLD) Higher Composite GWRS
Trailing 12M Revenue (USD)
Operating Scale
N/A $61M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 71.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 2.89x PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($73M Net Cash) $26M EBITDA ($3.13 Book/Sh · 2.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GWRS +57.65 pp
AARD: -76.64% · GWRS: -18.99%
3M Horizon GWRS +54.97 pp
AARD: -86.59% · GWRS: -31.62%
6M Horizon GWRS +68.32 pp
AARD: -79.68% · GWRS: -11.36%
1Y Horizon GWRS +64.91 pp
AARD: -91.18% · GWRS: -26.27%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AARD vs GWRS. Trailing 12-month operating profitability (AARD 0.0% vs GWRS 12.6%) and valuation multiples (AARD N/M vs GWRS 58.2x Forward P/E) are benchmarked directly in Pillar 4 below.

AARD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-66.0% · N/M
GWRS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$61M
Gross Margin71.7%
Op. Margin12.6%
ROE / Fwd P/E2.6% · 58.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AARD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 147.3%
IV Percentile 26th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact AARD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GWRS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 60.9%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GWRS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AARD Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $21.9M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GWRS Moat Profile Cyclical / Execution-Driven Positioning
Utilities - Regulated Water Operator
Competes within the Utilities - Regulated Water value chain with $191.6M market capitalization and 12.6% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($36M)
90D Engineering Disclosures 0 Published

Investor FAQ AARD vs GWRS Key Questions & Quantitative Answers

As of Nov 20, 2026, Global Water Resources, Inc. (GWRS) is the stronger overall head-to-head candidate over Aardvark Therapeutics, Inc. (AARD) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AARD carries a Unified Composite Score of 45.9/100 (HOLD) at $0.92 (N/M Forward P/E, 0.0% operating margin), whereas GWRS carries 52.7/100 (HOLD) at $6.40 (58.2x Forward P/E, 12.6% operating margin). Technical & Structure Timing Caution: AARD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.6); meanwhile GWRS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GWRS leads the Growth & Scale pillar: AARD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with GWRS at +5.0% YoY revenue growth and -50.0% YoY earnings growth on $61M TTM revenue (71.7% gross margin, 12.6% operating margin). On trailing 12-month operating scale, AARD generates N/A in USD-normalized revenue versus $61M for GWRS. In operating R&D and SG&A reinvestment, AARD deploys N/A (0 90-day corporate R&D disclosures) versus 59.1% of Rev ($36M) (0 disclosures) for GWRS.

GWRS screens cheaper on headline valuation multiples. AARD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GWRS trades at 58.2x Forward P/E, 80.0x Trailing P/E, 2.89x PEG, and 3.1x EV/Revenue (42.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AARD (-66.0% ROE) versus GWRS (2.6% ROE) capital efficiency.

In options market volatility and institutional positioning, AARD carries 147.3% implied volatility (26th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.84β · 284% Vol realized risk). By comparison, GWRS carries 60.9% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.